Affinity Asset Advisors’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-55,000
Closed -$1.08M 80
2021
Q3
$1.08M Buy
+55,000
New +$2.09M 0.27% 54

Other funds holding CELL

Affinity Asset Advisors's CELL Position: Q4 2021 in Review

Affinity Asset Advisors sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2021, closing a stake of 55,000 shares — an estimated $1.08M sold.

Affinity Asset Advisors first reported a position in CELL in Q3 2021 and held it in 1 quarter. The position peaked at $1.08M in Q3 2021. 132 funds tracked by Wall St. Rank hold CELL as of Q4 2021.

  • Affinity Asset Advisors reported no remaining PhenomeX Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Affinity Asset Advisors sold 55,000 PhenomeX Inc. Common Stock shares in Q4 2021, an estimated $1.08M.
  • Affinity Asset Advisors first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Affinity Asset Advisors's PhenomeX Inc. Common Stock position peaked at $1.08M in Q3 2021.
  • 132 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2021.

Based on Affinity Asset Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.